These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4937217)

  • 1. Effect of purified luteinizing hormone releasing factor on normal and hypogonadotrophic anosmic men.
    Naftolin F; Harris GW; Bobrow M
    Nature; 1971 Aug; 232(5311):496-7. PubMed ID: 4937217
    [No Abstract]   [Full Text] [Related]  

  • 2. ICSH(LH) and FSH levels in plasma after i.v. administration of LH-RH in impaired gonadal function.
    Wiegelmann W; Solbach WG; Kley KH; Zimmermann H; Krüskemper HL
    Acta Endocrinol Suppl (Copenh); 1973; 173():95. PubMed ID: 4579943
    [No Abstract]   [Full Text] [Related]  

  • 3. Effectf of synthetic luteinizing hormone-releasing hormone (LH-RH) in two brothers with hypogonadotropic hypogonadism and anosmia.
    Zárate A; Kastin AJ; Soria J; Canales ES; Schally AV
    J Clin Endocrinol Metab; 1973 Mar; 36(3):612-4. PubMed ID: 4568177
    [No Abstract]   [Full Text] [Related]  

  • 4. LH-secretion after synthetic LH-RH in the male under normal and pathological conditions.
    Schulz F; Guthoff R; Müller A; Retiene K
    Acta Endocrinol Suppl (Copenh); 1973; 173():93. PubMed ID: 4579942
    [No Abstract]   [Full Text] [Related]  

  • 5. LH, FSH and testosterone in plasma following LH-RH infusion: a combined test for pituitary and Leydig cell function.
    Kley HK; Wiegelmann W; Nieschlag E; Solbach HG; Zimmermann H; Krüskemper HL
    Acta Endocrinol (Copenh); 1974 Mar; 75(3):417-27. PubMed ID: 4592543
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical experience with hypothalamic releasing hormones. 2. Luteinizing hormone-releasing hormone and other hypophysiotropic releasing hormones.
    Kastin AJ; Gual C; Schally AV
    Recent Prog Horm Res; 1972; 28():201-27. PubMed ID: 4569230
    [No Abstract]   [Full Text] [Related]  

  • 7. Short- and long-term effects of clomiphene citrate on the pituitary-testicular axis.
    Santen RJ; Leonard JM; Sherins RJ; Gandy HM; Paulsen CA
    J Clin Endocrinol Metab; 1971 Dec; 33(6):970-9. PubMed ID: 5135636
    [No Abstract]   [Full Text] [Related]  

  • 8. [Response of gonadotropins to clomiphene and the Gn-RH in the Maestre de San Juan-Kallmann syndrome].
    Palacios Mateos JM; Rodríguez Poyo-Guerrero P; Iglesias Reymunde T; García Almansa A; Estevez C
    Rev Clin Esp; 1977 Apr; 145(1):29-31. PubMed ID: 323933
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypogonadotropic eunuchoidism. I. Clinical study of the mode of inheritance.
    Santen RJ; Paulsen CA
    J Clin Endocrinol Metab; 1973 Jan; 36(1):47-54. PubMed ID: 4404632
    [No Abstract]   [Full Text] [Related]  

  • 10. Anosmia and hypogonadism with ovarian mosaicism.
    Jones JR; Kemmann E; Cresci J; Solish GI
    Am J Obstet Gynecol; 1975 Apr; 121(7):991-4. PubMed ID: 1078755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypogonadism in chromatin-negative phenotypic male subjects.
    Donohue JP
    J Urol; 1970 May; 103(5):645-51. PubMed ID: 5309808
    [No Abstract]   [Full Text] [Related]  

  • 12. Clomiphene citrate, L-dopa and synthetic Gn-RH in evaluation of hypothalamic-pituitary function. Their effects of plasma LH and FSH in hypogonadotropic and hypergonadotropic hypogonadism.
    Delitala G; Masala A; Alagna S
    Panminerva Med; 1977; 19(1):15-26. PubMed ID: 319410
    [No Abstract]   [Full Text] [Related]  

  • 13. [The diagnostic significance of synthetic LH-RH (luteinizing hormone-releasing hormone) in evaluating gonadotropic pituitary function (author's transl)].
    Solbach HG; Wiegelmann W; Kley HK; Zimmermann H; Krüskemper HL
    Dtsch Med Wochenschr; 1973 Nov; 98(45):2114-9. PubMed ID: 4585937
    [No Abstract]   [Full Text] [Related]  

  • 14. Isolated hypogonadotrophic hypogonadism: a family with autosomal dominant inheritance.
    Dean JC; Johnston AW; Klopper AI
    Clin Endocrinol (Oxf); 1990 Mar; 32(3):341-7. PubMed ID: 2111748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrinological studies in patients with Kallmann's syndrome.
    Wiegelmann W; Solbach HG; Bethge H; Reinwein D; Schade C; Zimmermann H
    Acta Endocrinol Suppl (Copenh); 1971; 152():63. PubMed ID: 5313574
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypothalamic-pituitary function in the olfacto-genital syndrome.
    Antaki A; Somma M; Wyman H; Van Campenhout J
    J Clin Endocrinol Metab; 1974 Jun; 38(6):1083-9. PubMed ID: 4364809
    [No Abstract]   [Full Text] [Related]  

  • 17. [3 cases of hypogonadotropic hypogonadism with anosmia].
    Festa B; Candido R; Quirino R; Rampone N; Riccio M; Torella M
    Arch Ostet Ginecol; 1979; 84(3-4):203-11. PubMed ID: 317991
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of synthetic gonadotrophin-releasing hormone in secondary amenorrhoea.
    Akande EO; Bonnar J; Carr PJ; Corker CS; Dutton A; MacKinnon PC; Robinson D
    Lancet; 1972 Jul; 2(7768):112-6. PubMed ID: 4113894
    [No Abstract]   [Full Text] [Related]  

  • 19. [Case of Kallmann's syndrome].
    Kosmala U
    Endokrynol Pol; 1969; 20(1):1-3. PubMed ID: 5316679
    [No Abstract]   [Full Text] [Related]  

  • 20. Further studies on the pathophysiology of testicular feminization syndrome.
    Mauvais-Jarvis P; Crepy Q; Bercovici JP
    J Clin Endocrinol Metab; 1971 Apr; 32(4):568-71. PubMed ID: 5313332
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.